Veronika Skvortsova emphasized that the vaccine had undergone all clinical tests and currently a combined first and second phase of clinical research was in progress
FBMA vaccine to provide protection against all coronavirus strains — agency chief
Понравилась статья? Подпишитесь на канал, чтобы быть в курсе самых интересных материалов
Подписаться